-
CHANGING THE RULES OF THE GAME: AN AI-DRIVEN GAME-THEORETIC ANALYSIS OF THE CAUSAL DRIVERS IN EARLY-ONSET MALIGNANCY
Mar 18, 2026, 21:38 PM -
BETA-BLOCKER USE AND BREAST CANCER OUTCOMES: A SCOPING REVIEW
Mar 18, 2026, 21:38 PM -
COMPARATIVE VALUE-BASED PERFORMANCE ACROSS NUTRITION, PSYCHOLOGY, AND PHYSIOTHERAPY CARE PATHWAYS USING PATIENT-REPORTED OUTCOMES, EXPERIENCE, AND COST DATA
Mar 18, 2026, 21:38 PM -
IMPROVING THE TRANSPORTABILITY OF GLOBAL RCT EVIDENCE TO THE US POPULATION AND OTHER TARGET MARKETS: A STRUCTURED FRAMEWORK FOR HEALTH ECONOMIC MODELING
Mar 18, 2026, 21:38 PM -
REAL-WORLD PREDICTORS OF TREATMENT FAILURE AND NS5A RESISTANCE SELECTION IN GENOTYPE 3 HEPATITIS C: A MULTICENTER COHORT WITH LONGITUDINAL SEQUENCING AND IN-SILICO MODELLING
Mar 18, 2026, 21:38 PM -
COST COMPARISON OF RFVIIA AND PLASMA-DERIVED FACTOR VII FOR BLEEDING MANAGEMENT IN COLOMBIA
Mar 18, 2026, 21:38 PM -
QUANTIFYING THE IMPACT OF ADHERENCE TO HEREDITARY CANCER TESTING ON COLORECTAL CANCER BURDEN: A MICROSIMULATION MODEL
Mar 18, 2026, 21:38 PM -
COMPARISON OF GUIDELINE-RECOMMENDED AND PRELIMINARY RISK-BASED APPROACHES TO SELECTION OF LUNG CANCER PATIENTS FOR LYMPH NODE STAGING
Mar 18, 2026, 21:38 PM -
COMPARISON OF 5-YEAR SURVIVAL AND ESTIMATED LIFE YEARS BETWEEN TWO DATA CUTS OF STUDY 309/KEYNOTE-775
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF ABIRATERONE, APALUTAMIDE, ENZALUTAMIDE, AND DOCETAXEL DOUBLETS FOR METASTATIC HORMONE-SENSITIVE PROSTATE CANCER: A REAL-WORLD EVIDENCE ANALYSIS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF TIRZEPATIDE FOR THE MANAGEMENT OF HEART FAILURE WITH PRESERVED EJECTION FRACTION AND OBESITY
Mar 18, 2026, 21:38 PM -
FROM TOKYO TO WASHINGTON: IMPACT OF JAPAN’S HTA ENVIRONMENT ON U.S. MFN PRICING AND LAUNCH STRATEGY
Mar 18, 2026, 21:38 PM -
EVALUATING PATIENT REPORTING HABITS IN CLINICAL TRIALS: A COMPARISON OF EVENT-DRIVEN VS. PROMPTED EVENING EDIARY ENTRIES
Mar 18, 2026, 21:38 PM -
PREDICTING TREATMENT-RESISTANT DEPRESSION AMONG MEDICARE BENEFICIARIES USING MACHINE LEARNING
Mar 18, 2026, 21:38 PM -
CLAIMS DATA FOR POST-MARKET SAFETY INVESTIGATIONS: LESSONS FROM A REAL-WORLD ONCOLOGY COHORT
Mar 18, 2026, 21:38 PM -
HEALTHCARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF HERPES ZOSTER IN IMMUNOCOMPETENT OLDER ADULTS IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
GENERIC ENTRY AND THE EARLY IMPACT ON U.S. PHARMACEUTICAL SPENDING
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF INTENSIVE VERSUS STANDARD HYPERTENSIVE THERAPY AMONG TYPE 2 DIABETIC PATIENTS WITH HYPERTENSION
Mar 18, 2026, 21:38 PM -
A STATISTICAL MODELING FRAMEWORK FOR PROCESS-MINED REAL-WORLD DATA SUPPORTING HTA OF MULTIPLE MYELOMA TECHNOLOGIES IN A BRAZILIAN HEALTH MAINTENANCE ORGANIZATION
Mar 18, 2026, 21:38 PM -
REAL-TIME AND SHORT RECALL OF FLARES IN PNH, CAPTURED THROUGH LONGITUDINAL HOME-REPORTED OUTCOMES
Mar 18, 2026, 21:38 PM
